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Abstract 
Streptococcus suis is one of the most important bacterial swine pathogens affecting post-weaned piglets, causing 
mainly meningitis, arthritis and sudden death. It not only results in severe economic losses but also raises concerns 
over animal welfare and antimicrobial resistance and remains an important zoonotic agent in some countries. The 
definition and diagnosis of S. suis-associated diseases can be complex. Should S. suis be considered a primary or 
secondary pathogen? The situation is further complicated when referring to respiratory disease, since the pathogen 
has historically been considered as a secondary pathogen within the porcine respiratory disease complex (PRDC). Is 
S. suis a respiratory or strictly systemic pathogen? S. suis is a normal inhabitant of the upper respiratory tract, and the 
presence of potentially virulent strains alone does not guarantee the appearance of clinical signs. Within this unclear 
context, it has been largely proposed that co-infection with some viral and bacterial pathogens can significantly influ-
ence the severity of S. suis-associated diseases and may be the key to understanding how the infection behaves in the 
field. In this review, we critically addressed studies reporting an epidemiological link (mixed infections or presence of 
more than one pathogen at the same time), as well as in vitro and in vivo studies of co-infection of S. suis with other 
pathogens and discussed their limitations and possibilities for improvement and proposed recommendations for 
future studies.
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1 Introduction
Streptococcus suis is an important bacterial pathogen of 
swine with a worldwide distribution [1]. The most com‑
mon clinical and pathological outcomes of the infection 
are meningitis, arthritis, endocarditis, septicemia and 
sudden death [2]. The definition of Streptococcus suis‑
associated diseases should be based on the combination 
of the presence of clinical signs, gross and/or micro‑
scopic lesions and bacterial isolation (in either predomi‑
nance or pure culture) in affected organs and/or tissues. 
However, even after bacterial isolation, interpretation 
of the role of S. suis as a primary pathogen is not always 
easy. Furthermore, since diagnosis in the field may some‑
times be based solely on clinical observations, differentia‑
tion with infections caused by other pathogens (such as 
Glaesserella parasuis) is difficult. The more specific role 
of S. suis in pneumonia is also a topic of debate. Clinical 
signs and mortality are mainly observed in weaned and 
(rarely) in suckling piglets and much less commonly in 
grower‑finisher pigs. The infection caused by the patho‑
gen not only results in severe economic losses but also 
raises animal welfare concerns. In addition, S. suis‑asso‑
ciated diseases are difficult to control [2]. Even when the 
carrier rate of S. suis is high, the incidence of the disease 
varies from period to period and is usually less than 5% 
[2]. However, this is usually the case when antimicrobi‑
als (if allowed) are used as prophylactic/metaphylactic 
measures. One of the main problems is that antimicrobi‑
als that have efficacy are those the industry is trying to 
reduce given their importance in both human and veteri‑
nary medicine [2]. Recent data on antimicrobial suscep‑
tibility of S. suis are alarming. High rates of resistance to 
macrolides/lincosamides and tetracyclines are observed 
and attributed to the intensive use of antimicrobials in 
pigs [3]. S. suis is considered a niche for antimicrobial 
resistance and represents a high risk of transmission of 
such resistance to other veterinary and human pathogens 
due to the presence of mobile genetic elements carrying 
resistance genes transferable at high frequency within the 
species and, even more alarmingly, toward other bacte‑
rial species [3, 4]. S. suis is also considered an important 
zoonotic infection. The target populations are mainly 
workers in the swine and pork industry (Western coun‑
tries), the general population due to close contact with 
pigs (China and other Asian countries) and individuals 
who consume raw or undercooked pork or pork by‑prod‑
ucts (Vietnam, Thailand and Laos) [5, 6].
S. suis had originally been classified into 35  serotypes 
based on the antigenicity of the capsular polysaccharide, 
which is suggested to be a major virulent factor [7]. How‑
ever, six of the serotypes (serotypes 20, 22, 26, 32, 33 and 
34) have been reclassified as belonging to other bacterial 
species [8, 9]. The distribution of serotypes recovered 
from diseased pigs in different geographical regions var‑
ies, although serotypes 2 and 9 are the most prevalent in 
several European countries [1]. Serotype 2 is, by far, the 
most common serotype affecting humans, followed by 
serotype  14 [1]. The distribution of serotypes affecting 
pigs in North America is different, with no clear preva‑
lence of serotype  2 [10, 11]. Highly, intermediately and 
low virulent serotype  2 strains have been characterized 
[7, 12]. Further studies using multilocus sequence typ‑
ing (MLST) showed that sequence type (ST)  1 strains 
(with other clonal complex 1 strains) normally found in 
Europe and Asia present higher virulence potential and 
are mainly isolated from diseased pigs and humans [6].
S. suis is normally present in the tonsils and naso‑
pharynx of most healthy pigs [13, 14] and some authors 
therefore classify the bacterium as “pathobionts” [15]. 
The conditions under which certain serotypes/strains of 
S. suis become pathogenic and cross the mucosal barrier 
into the blood causing a systemic infection are not fully 
understood [16]. A plethora of potential virulent factors 
has been described, although there is still a debate sur‑
rounding their significance to the pathogenesis of dis‑
eases linked to S. suis infection [7]. It is believed that, 
under some circumstances, S. suis does not act alone and 
takes advantage of concomitant or previous infections 
with other pathogens. Indeed, since co‑infections have 
been largely been associated with the increase in clini‑
cal disease caused by S. suis, we will critically discuss the 
data available in the literature that directly or indirectly 
address the issue. The definitions of co‑infection, super‑
infection and mixed infections are not always clear but 
were plainly explained in a recent review [17]. We will 
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use the term mixed infection when there is an epidemio‑
logical link only (detection of more than one pathogen in 
organs/tissues) and co-infection for in  vitro and in  vivo 
studies that specifically address the interaction between 
S. suis and other pathogens.
2  Complexity of the transition from infection (or 
colonization) to clinical disease caused by S. suis
Should S. suis be considered a primary or secondary/
opportunistic pathogen? As mentioned, S. suis is a nor‑
mal inhabitant of the upper respiratory tract [2]. The 
presence of potentially virulent strains alone does not 
guarantee the appearance of clinical signs, the latter 
observed sometimes in the absence of such strains, as 
occurs in North America where highly virulent Eura‑
sian strains are seldom isolated [2]. Indeed, high doses 
of inoculum (mostly with virulent serotype 2 strains) 
and aggressive non‑natural inoculation routes (intra‑
peritoneal or intravenous) or sometimes two simultane‑
ous routes of infection (intranasal and intramuscular) 
have been used in experimental trials using conventional 
pigs to reproduce clinical disease [18–21]. On the other 
hand, mortalities up to 20% with non‑serotype 2 strains 
may be observed in the natural infection in the field if 
no medication is used [22]. As mentioned, the definition 
of virulence for a given strain of S. suis is not simple, a 
fact that is even truer for serotypes other than serotype 2, 
which have been less studied and for which animal mod‑
els to reproduce the disease are almost inexistent. For 
example, serotype  9 virulent strains must be adminis‑
trated intravenously to susceptible pigs to reproduce 
disease [23], even though this serotype is the most preva‑
lent among diseased pigs in several European countries 
[1]. The situation in North America is even more com‑
plicated since serotypes 2 and 9 strains are very different 
from predominant virulent strains in Europe and display 
lower virulence [2, 24]. Indeed, serotype  1/2, a poorly 
studied non‑zoonotic serotype, is the predominant sero‑
type recovered from clinical cases in the USA and Can‑
ada [10 and unpublished data]. It has been proposed 
that, in addition to the potential virulence of the strain(s) 
present in the herd, several factors may influence the 
appearance of clinical signs (Figure  1): (a) environmen‑
tal factors; (b) management factors; (c) host factors and/
or (d) the presence of co‑infections. Environmental fac‑
tors that may influence the appearance of S. suis‑related 
diseases include poor ventilation, high humidity, inad‑
equate sanitation, high levels of dust and ammonia and 
large temperature variations between night and day [2]. 
Management factors such as high level of cross‑fostering, 
Figure 1 Factors influencing the appearance of clinical signs of Streptococcus suis infection. 
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overcrowding, teeth clipping and tail docking, ear notch‑
ing, mixing pigs of different ages, poor adaptation to solid 
feed in the nursery and low levels of vitamin E have also 
been cited as playing important roles [2]. Host factors 
such as high levels of stress and the presence/absence of 
anti‑S. suis antibodies may also influence the appearance 
of clinical disease. Indeed, it has been shown that clini‑
cal signs appear when the level of maternal antibodies is 
low [22, 25]; antibodies slowly increase at the end of the 
post‑weaning period, and animals become more resistant 
to infection [26]. These antibodies would not necessarily 
be all specific to the virulent strains of S. suis present in 
the herd (unpublished observations) but probably also to 
other S. suis or even other streptococci that are normally 
present in tonsils [25]. Finally, co‑infections have been 
suggested to play a major role in the development of S. 
suis disease. Indeed, co‑infections/mixed infections of 
different swine pathogens with S. suis have been reported 
and suggested in the literature, although there is still a 
certain lack of scientific support for many of them. This is 
the main reason why we address the topic in this review.
3  Should S. suis be considered a respiratory 
or systemic pathogen? Or both?
Although many studies addressed the role of S. suis in 
respiratory diseases, a pathogen’s route of entry should 
be differentiated from the induced pathology. Although 
there is a proposed hypothesis of intestinal translocation 
(still to be confirmed) [27], it is widely accepted that the 
main route of infection for systemic S. suis disease is the 
respiratory route [2], and airborne transmission of the 
infection has clearly been demonstrated [28]. Within this 
context, it may be argued whether S. suis should be con‑
sidered as a true respiratory pathogen. Infectious agents 
involved in porcine respiratory disease complex (PRDC) 
are classified into primary or secondary (or opportunis‑
tic) pathogens [17]. Primary pathogens are defined as the 
ones that can infect the animal as the first unique patho‑
gen and then facilitate secondary or opportunistic co‑
infection(s). S. suis is usually considered as a secondary/
opportunistic pathogen [17]. However, the role of S. suis 
in respiratory pathology, even as an opportunistic agent, 
is still not clear. Studies based on natural infection cases 
indicate that S. suis may cause pulmonary lesions gener‑
ally described as suppurative bronchopneumonia and/or 
fibrino‑hemorrhagic pleuropneumonia [29–31]. How‑
ever, in most cases of natural infections, other concomi‑
tant bacteria were also isolated, and the specific role of S. 
suis is difficult to evaluate [32]. Respiratory clinical signs 
are usually not observed after experimental infection 
with S. suis, and the clinical outcomes are mainly septice‑
mia, meningitis and/or arthritis, which are also observed 
in studied cases of airborne transmission [28, 33]. The 
few cases in which respiratory signs were observed are 
frequently associated with heart lesions (endocarditis or 
pericarditis) with no pulmonary involvement (unpub‑
lished observations). Intranasal experimental infections 
may, under some circumstances (previous irritation of 
nasal mucosa), induce mostly meningitis and arthritis 
with no lung lesions associated with respiratory prob‑
lems ([33] and unpublished data). Intranasal infection of 
highly susceptible caesarian‑derived, colostrum‑deprived 
piglets also led to systemic disease [34]. More recent co‑
infection studies in conventional pigs (see below) showed 
some lung lesions following S. suis infection, although no 
indication of the presence of other opportunistic bacte‑
rial pathogens in these studies is discussed [20]. Indeed, 
when evaluating isolates of S. suis for its potential viru‑
lence (pathotypes), those recovered from lungs are either 
not included in the study or often considered as possibly 
opportunistic [10, 35]. S. suis may also reach lungs as 
post‑mortem invasion, and that is one of the causes that 
disqualify the use of isolates recovered from lungs to pro‑
duce autogenous vaccines [26].
Finally, S. suis recovered from the lungs of young ani‑
mals with respiratory signs and pulmonary lesions should 
be differentiated from those recovered from lungs at 
slaughter. S. suis rarely induce disease in finisher ani‑
mals due to the high levels of antibodies present in 
older animals [25], and the detection of the pathogen in 
such mixed infections at slaughter should not be taken 
into consideration. Indeed, S. suis may be isolated from 
healthy lungs without lesions, probably due to the fact 
that some carrier isolates may go from the upper to the 
lower respiratory tract during agony [2, 36].
4  S. suis and viral mixed and/or co‑infections
Mixed infections of S. suis with swine viruses are a fre‑
quent finding in swine herds. These interactions are 
believed to have a synergistic effect, resulting in the 
aggravation of clinical signs and increased mortality. 
However, few controlled studies on real co‑infections 
have been conducted. The most important viral patho‑
gens that have been suggested to be associated with 
S.  suis disease are porcine reproductive and respiratory 
syndrome virus (PRRSV) and, to a lesser extent, swine 
influenza virus (SIV) and porcine circovirus  2 (PCV‑2). 
Studies that consider other viruses are rare. To better 
understand the importance of S. suis co‑infections with 
swine viruses, we will discuss the main findings from the 
reported mixed infections, as well as controlled in vitro 
and in  vivo assays that may help elucidate the interac‑
tions. The important details and conditions of in  vitro 
and in vivo experimental studies with S. suis and viruses 
are summarized in Tables 1 and 2.
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4.1  S. suis and PRRSV mixed and co-infections
For over 30  years, PRRSV has been one of the leading 
viral diseases in pigs, causing significant losses in the 
swine industry, causing more than $600 million in losses 
every year in the USA alone [37]. The clinical signs can 
range from reproductive failure in pregnant sows to 
severe respiratory clinical signs in weaned and growing 
pigs. PRRSV strains have considerable genetic variabil‑
ity (approximately 60%) and are categorized as PRRSV1 
(European genotype) and PRRSV2 (North American gen‑
otype) [38]. PRRSV can cause severe disease alone or act 
in concert with other viruses or bacteria to significantly 
contribute to PRDC [40–42]. It has been reported that 
PRRSV infects pulmonary interstitial, alveolar and intra‑
vascular macrophages with consequent decreased phago‑
cytic activity and altered innate immune response in the 
respiratory tract, opening the door to other opportunistic 
viral and bacterial pathogens [43]. However, there are still 
some gaps with regard to the specific cell types the virus 
infects [37].
4.1.1  PRRSV‑S. suis mixed infections
There is strong unwritten evidence of a clear synergic 
association between PRRSV and S. suis from the clini‑
cal perspective, and most swine practitioners strongly 
believe that positive unstable (Category  I) herds [44] 
are more prone to serious problems of S. suis disease 
than PRRSV stable or free herds. Some examples in the 
literature describe the simultaneous detection of both 
pathogens in the same farm (mixed infections). Although 
PRRSV seroprevalence is a good indicator of swine herd 
exposure to the virus, RT‑PCR analysis is required to 
detect active infections and confirm mixed infections of 
PRRSV with other swine pathogens [45]. For example, 
RT‑PCR analysis of oral fluids from pig farms in Korea 
showed that PRRSV and S. suis were frequently detected 
together (around 50%) in 3  to  7  week‑old piglets [46]. 
Studies performed at slaughter in Canada showed that 
RT‑PCR analysis of swine pathogens present on tonsils 
detected S. suis and PRRSV in 53.7% and 22% of samples, 
respectively [13]. Similarly, another study at slaughter 
showed that lungs that were RT‑PCR positive for PRRSV 
have significantly higher odds of being positive for S. 
suis [47]. These data (from both abattoirs and non‑clin‑
ical samples) do not reveal the nature of the pathogens’ 
interaction and their possible synergistic effect due to the 
endemic characteristics of PRRSV and ubiquitous pres‑
ence of S. suis. Indeed, it is important to state that both 
pathogens may be present in herds without any associ‑
ated clinical signs of disease.
In Vietnam, Hoa et  al. showed an increased isolation 
rate of highly virulent S. suis serotype 2 in the blood and 
internal tissues of diseased pigs from PRRSV‑affected 
farms (18%) compared to those that were not affected 
by the virus infection (2%) [48]. Interestingly, a temporal 
and spatial association of occurrence of human meningi‑
tis caused by S. suis and PRRSV outbreaks in pig farms 
was observed in that country [49]. It should be noted that 
the study addresses association and not causality. The 
study also has limitations (clearly stated by the authors): 
incomplete details on PRRSV outbreaks, differences in 
sample collection, underestimation of the real prevalence 
and distribution of PRRSV outbreaks and lack of details 
on individual patient data that may constitute confound‑
ing factors.
The few epidemiological studies and clinical obser‑
vations by practitioners around the world point to the 
importance of the S. suis‑PRRSV association with regard 
to the occurrence of severe disease in pigs. However, 
the mechanisms behind the observed synergistic effect 
of both pathogens have yet to be explained. To better 
understand the cellular, immunological and molecu‑
lar implications behind this synergy, some in  vitro and 
in vivo models have been developed.
4.1.2  In vitro studies on the interactions between S. suis 
and PRRSV
Owing to the characteristics of PRRSV, S. suis co‑infec‑
tion studies mainly addressed the interactions with cells 
of the innate immune system. Although the pathogenesis 
of the infection caused by S. suis is not yet completely 
understood [7], it is believed that its interaction with res‑
piratory phagocytic cells may be one of the initial steps of 
the infection [16]. In this first line of defense, pulmonary 
alveolar macrophages (PAMs) play an essential role in the 
innate immune response against pathogens through bac‑
terial phagocytosis and elimination [42]. Since these cells 
are also among PRRSV’s most important targets, they 
may represent an interesting model to study co‑infec‑
tion effects [43]. The hypothesis behind the PAM cells’ 
use in co‑infection studies is that a prior PRRSV infec‑
tion would reduce S. suis phagocytosis either by reducing 
phagocyte activity or inducing cell apoptosis. However, 
under normal conditions, S. suis possesses a thick cap‑
sule that usually prevents bacterial phagocytosis—a 
fact confirmed by different research groups using non‑
encapsulated mutants [7]. It is important to note that the 
bacteria that are internalized do not survive intracellu‑
larly [50]. So, it may also be hypothesized that although 
the internalization of S. suis is a rare event, a previous 
viral infection may affect the intracellular killing of bac‑
teria, which may influence the outcome of the disease. 
Another important aspect of the interaction of S. suis 
with phagocytes is the capacity to induce inflammation. 
Indeed, it has been shown that an excess of inflammation 
is a hallmark of S. suis disease [7]. Hence, two pathogens 
Page 7 of 22Obradovic et al. Vet Res           (2021) 52:49  
acting together would increase the inflammatory reaction 
through an increase in the secretion of pro‑inflammatory 
cytokines. Still, immunosuppression has been demon‑
strated in some PRRSV infection studies and thus may 
lead to a higher susceptibility to bacterial co‑infection in 
affected pigs [51, 52]. Interestingly, the two processes are 
not necessarily in contradiction, since the dual activity of 
PRRSV (immunosuppression but increased inflamma‑
tion) has been observed in cases of PRRSV and porcine 
respiratory coronavirus co‑infection studies in pigs [53].
Several studies addressed the interaction between 
S. suis and PAMs [50, 54, 55], but only one reported 
how a previous PRRSV infection of these cells affects 
S. suis phagocytosis and inflammation (Table  1) [20]. 
PAMs infected with a highly pathogenic PRRSV geno‑
type  2  strain and a poorly characterized S. suis sero‑
type  2  strain showed increased bacterial phagocytosis 
and survival [20]. In addition, co‑infection significantly 
increased the mRNA expression of most pro‑inflamma‑
tory cytokines tested, including interleukin (IL)‑1β, IL‑6, 
IL‑8, chemokine (C–C motif ) ligand  4 (CCL4), tumor 
necrosis factor‑α (TNF‑α) and interferon‑β (INF‑β). 
Authors concluded that the deleterious effect of the co‑
infection was mainly due to excessive inflammation [20]. 
Surprisingly, no other study addressed the effect of co‑
infection on these cells.
Another study addressed the effect of co‑infection 
using monocytes and swine bone marrow‑derived den‑
dritic cells (BMDC) [56]. Both cell types were first 
infected with a PRRSV genotype  2  strain and then 
co‑infected with the European (ST1) virulent sero‑
type 2 P1/7 strain of S. suis (used in virulence studies by 
most laboratories) [56]. Unlike the previous study with 
PAMs, results showed that PRRSV significantly reduced 
the internalization of S. suis by the BMDC with no 
observed effect on bacterial intracellular survival [20]. No 
differences were observed with monocytes, which hardly 
allowed virus replication and poorly phagocytosed S. suis 
[56]. As shown with PAMs, microarray analysis revealed 
significant up‑regulation of pro‑inflammatory genes in 
co‑infected BMDC [56]. Previous S. suis research showed 
the capacity of the bacteria alone to induce the secretion 
of pro‑inflammatory cytokines involved in disease patho‑
genesis [57]. Co‑infection with PRRSV may exacerbate 
the inflammation by increasing the secretion of cytokines 
from immune cells, although this hypothesis should be 
confirmed in vivo. Unfortunately, there are no other stud‑
ies of co‑infection of these two important pathogens with 
phagocytic cells. Indeed, it has been shown that pulmo‑
nary intravascular macrophages may play an important 
role in PRRSV infection [58]. Although a possible asso‑
ciation between a virus‑dependent suppression of the 
functions of these cells and an increased susceptibility 
to S. suis secondary infection has been hypothesized, no 
study has specifically addressed this interaction. How‑
ever, an interesting feature of PRRSV is that it may affect 
the thymus and its ability to carry out its normal func‑
tions [52, 59]. In this way, pigs would be less able to resist 
and/or eliminate secondary infections. It has also been 
reported that S. suis infection can cause atrophy of the 
thymus and induce apoptosis of thymocytes, thus likely 
suppressing host immunity [60]. How these two patho‑
gens interact with this important immune organ is still 
unknown.
Finally, co‑infection studies with non‑immune cells 
have not been conducted. Since PRRSV induces nonsup‑
purative rhinitis and metaplasia of the turbinate epithe‑
lium, it has been suggested that it may predispose pigs to 
the colonization of the respiratory tract by S. suis sero‑
type  2, potentially creating a portal of entry for S. suis 
[61]. However, the hypothesis of virus predisposition to 
bacterial colonization has never been confirmed.
In summary, although it is widely accepted that a 
PRRSV infection increases the susceptibility to S. suis co‑
infection (see results in vivo below), it seems evident that 
there is a serious lack of scientific evidence that clearly 
explains the specific mechanisms involved in such inter‑
actions and more mechanistic studies are needed.
4.1.3  In vivo studies on the interactions between S. suis 
and PRRSV
Although a first report failed to demonstrate any influ‑
ence of PRRSV infection on an S. suis secondary infec‑
tion [62], further in  vivo experiments were carried out 
to demonstrate the synergistic effect of these pathogens 
on morbidity and the severity of clinical signs in pigs [20, 
52, 61, 63, 64]. The most common type of co‑infection 
model was developed by infecting animals intranasally 
with PRRSV and then, after 5  to  7  days, inoculating S. 
suis intranasally or intramuscularly (an overview of the 
important study parameters is shown in Table 2) [20, 61, 
63, 65]. Only one study addressed an intrauterine infec‑
tion with PRRSV (sows) followed by S. suis infection in 
piglets [52] (see below). Different PRRSV types (low to 
high virulent) and origins (North America or Asia), as 
well as S. suis serotype  2  (sometimes poorly character‑
ized) strains, were assayed. There is only one study that 
used a S. suis serotype  7  strain [65]. The consensus of 
these studies is that higher mortality and morbidity were 
observed in groups in which piglets were co‑infected by 
the two pathogens compared to those infected only with 
S. suis, independently of the virus genotype and S. suis 
serotype [20, 61, 65]. S. suis was cultured in higher num‑
bers from tissues and blood (bacteremia) of co‑infected 
animals compared to S. suis mono‑infected piglets and 
macroscopic and microscopic lesions in different internal 
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organs were significantly exacerbated in animals in the 
co‑infected groups [20, 61, 65]. In particular, co‑infected 
piglets had significantly more severe gross and micro‑
scopic interstitial pneumonia lesions, suggesting a pos‑
sible secondary role of S. suis in PRDC [20, 42, 65]. The 
co‑infection was able to reproduce similar morbidity and 
mortality to those observed in the high‑fever outbreak 
caused by atypical PRRSV in China [39]. Interestingly, 
a vaccine strain of PRRSV given intranasally prior to S. 
suis infection induced increased mortality compared to 
the single‑infected controls, although the mortality was 
lower than in the cases of co‑infection with a virulent 
PRRSV strain [61]. It must be noted that this was an off‑
label use of the PRRSV live attenuated vaccine, and it is 
unlikely that the vaccine would be administered intrana‑
sally under field conditions.
PRRSV is a causative agent of complex disease, attack‑
ing multiple organs. The infection of pregnant sows with 
PRRSV results in late abortion, early farrowing and still‑
born piglets [66]. Piglets from PRRSV infected sows are 
PRRSV positive and, in theory, would have a weakened 
immune system that predisposes them to other oppor‑
tunistic pathogens [66]. One animal model was developed 
to examine the effect of intrauterine PRRSV infection in 
piglets on susceptibility to further intranasal infection 
with S. suis serotype  2  [52]. To the authors’ knowledge, 
this is the only published study on adult PRRSV infection 
followed by S. suis piglet co‑infection. Pregnant gilts were 
either inoculated or not with PRRSV at 98  days of ges‑
tation (see Table 2) [52]. Five day‑old piglets born from 
these sows were inoculated intranasally with an S. suis 
serotype  2  strain [52]. The mortality rate, clinical signs, 
organ lesions and S. suis isolation from joints and brain 
in the co‑infected group were significantly higher com‑
pared to control non‑S. suis infected piglets and those 
infected with S. suis alone [52]. Increased susceptibility 
was explained as being linked to the immuno‑suppres‑
sion caused by the effect of PRRSV on innate immune 
cells. Indeed, PRRSV‑positive piglets had lesions in their 
thymus and bone marrow and significantly reduced 
numbers of leukocytes, including lymphocytes and 
monocytes [52]. In conclusion, this study showed that 
intrauterine PRRSV infection has significant effects on 
immune response and may increase the susceptibility of 
piglets to intranasal S. suis serotype 2 infections. Even so, 
the presence of confounding factors, especially concern‑
ing the experimental model used, must be considered. 
Piglets were deprived of sow’s colostrum, early‑weaned 
and challenged with bacteria at five days of life, which is 
rare in the field, where mostly post‑weaned animals are 
affected by S. suis [25, 52].
Other studies addressed the role of a pre‑infection 
with S. suis with subsequent PRRSV infection. One of 
these studies used 6‑week‑old PRRSV‑negative pig‑
lets weaned before one week of age and kept free of 
pathogens. Animals were intranasally inoculated with 
a bacterial cocktail containing S. suis and two other 
pathogens, mimicking sub‑clinical bacterial infec‑
tions observed in the field. One week later, piglets were 
challenged with PRRSV strains of different origins and 
variable virulence [64]. Results showed low mortality 
in general, although morbidity and lesions were more 
severe in piglets inoculated with a highly virulent Asian 
PRRSV strain [64]. The frequency of secondary bacte‑
rial pneumonia was directly associated with the clini‑
cal severity induced by the PRRSV strains evaluated. 
Levels of pro‑inflammatory cytokines were lower or at 
the same level in single or co‑infected animals, which 
contradict somehow previous in  vitro co‑infection 
studies [20, 56]. Another study used three‑week‑old 
conventional piglets that were inoculated intramus‑
cularly with S. suis serotype  2  strain and seven days 
later with a highly pathogenic PRRSV MLV‑like isolate 
[67]. Results showed that while virus or S. suis infec‑
tion caused transitional fever and moderate clinical 
signs, the co‑infection induced higher fever, anorexia 
and respiratory distress, leading to 60% mortality [67]. 
It should be noted that the route of animal infection 
with S. suis does not reflect natural conditions, and the 
results should be interpreted carefully.
The synergy between PRRSV and S. suis in vivo can‑
not be denied, and experimental infection studies gen‑
erally confirm this fact. However, there are still many 
variables in previous co‑infection studies to identify the 
mechanisms involved. The pathogenicity of the PRRSV 
strain is just one part of the puzzle, while other factors 
like stress, environment, host susceptibility and bacte‑
rial burden are some of the variables that may influence 
the clinical and pathological outcomes. One important 
point is also the strain of S. suis serotype  2 used: in 
many studies, strains are poorly characterized although 
it is well known that the virulence of serotype 2 strains 
is highly variable [7]. One study showed either no effect 
of co‑infection using one S. suis strain (with a North 
American phenotype) or a strong synergy when a sec‑
ond and different strain (with a Eurasian phenotype) 
was used [2, 63]. It is important to note that co‑infec‑
tions of PRRSV and typical North American serotype 2 
(ST28 or ST25) S. suis strains are frequently reported 
in Canada and the USA. Even though the virulence of 
these S. suis strains is probably lower than that of Eur‑
asian strains [7], a combination of other factors may 
have an influence on the effects of the co‑infection (Fig‑
ure  1). Interestingly, other than the study mentioned 
above, no co‑infection trials have been performed with 
typical North American S. suis strains.
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4.2  S. suis and swine influenza type A virus (SIV) mixed 
and co-infections
Swine influenza viruses (mainly type A) are able to cause 
respiratory disease in pigs worldwide, that can lead to 
10–15% mortality [68]. Influenza disease in pigs is highly 
contagious with no evident clinical signs or mild to mod‑
erate ones characterized by runny nose and coughing 
[69]. Swine influenza causes significant economic losses 
primarily due to weight loss, though some cases may be 
much more severe in co‑infection with other pathogens, 
such as M. hyopneumoniae, PRRSV and Actinobacillus 
pleuropneumoniae [68]. The three main SIV subtypes 
encountered in pigs are H1N1, H1N2, and H3N2, and 
since 2009, the pandemic H1N1 (pH1N1) has also been 
circulating in domestic pigs worldwide [70]. Influenza 
viruses cause respiratory disease by infecting the epi‑
thelial cells leading to cell apoptosis and the destruction 
of the mucosal barriers [71]. In addition, cell death is 
enhanced by the effect of cytokines and innate immune 
cells, which causes bronchitis and interstitial pneumonia 
[71].
4.2.1  SIV‑S. suis mixed infections
It is well known that influenza virus infections in humans 
are usually complicated by secondary bacterial infections, 
especially Streptococcus pneumoniae [72]. The capac‑
ity of SIV to aggravate respiratory bacterial infections 
in pigs has also been documented [73–75]. However, 
the potential of SIV and S. suis mixed or co‑infections 
to cause serious pulmonary disease has been much less 
studied and there are only a few published reports. Sero‑
logical data indicate a link between SIV and S. suis in 
swine farms in China, although detailed information on 
the correlation of antibody titers and isolation of these 
two pathogens from healthy or diseased animals is miss‑
ing [76]. The report on SIV H1N1 virus infections in pigs 
in England provided more information, since data show 
that clinical signs were mostly mild with low mortality 
in older animals infected with SIV alone. Increased mor‑
tality was observed in nursery pigs, in which influenza 
infection was complicated by environmental stress and/
or co‑infections, with S. suis being the most prevalent 
pathogen isolated in these cases [77]. S. suis serotypes 
1, 2, 14,  and 24 as well as some untypable isolates were 
detected in SIV‑infected pigs with severe signs of cough, 
meningitis, lameness and sudden death [77]. These 
results suggest that SIV may complicate S. suis infections 
observed in the field.
4.2.2  In vitro studies on the interaction between S. suis 
and SIV
Different in  vitro and ex  vivo tissue cell culture mod‑
els were therefore developed to examine the complex 
mechanism of host–pathogen interactions during co‑
infection (Table  1). Most in  vitro studies address the 
influence of a previous SIV infection on secondary S. suis 
infection. However, an earlier study using the Madin‑
Darby canine kidney (MDCK) cell line model showed 
that the supernatant from a S. suis serotype 2 strain can 
increase the infection ability of SIV H3N2 for these cells 
[78]. The results may suggest that S. suis has secretory 
factors that facilitate SIV entrance even in the absence 
of bacteria. It should be noted that MDCK cells do not 
resemble swine respiratory mucosal cells and, in this 
study, the effect of the supernatant was evaluated in a 
closed environment (a well) in which extracellular fac‑
tors of S. suis are concentrated. The results have not been 
confirmed or invalidated by other research groups.
The first study that demonstrated the effect of a previ‑
ous SIV infection in cells followed by a subsequent S. suis 
infection was carried out using neonatal tracheal por‑
cine epithelial (NTPr) cells [79]. SIV H1N1 pre‑infected 
cells enabled bacterial adhesion and invasion levels that 
were over 100 times higher compared to those of control 
cells. Inhibition studies confirmed that bacterial capsu‑
lar sialic acid moiety is responsible for the binding to the 
viral hemagglutinin expressed on the NTPr cell surface 
[79]. Also, pre‑incubation of S. suis with SIV H1N1 sig‑
nificantly increased bacterial adhesion to epithelial cells 
and epithelial cell invasion. Similar results were obtained 
with other S. suis sialic‑acid positive serotypes (such as 
serotypes 1 and 14), but not with serotypes that lack the 
presence of such sugar moiety in their capsular polysac‑
charides [79]. The results were confirmed by an inde‑
pendent research group using the same cell type and both 
SIV H1N1 and H3N2 subtypes [80]. The latter study also 
revealed that viruses bound to bacteria retained infectiv‑
ity but induced only tiny plaques compared to the control 
virus. In contrast, bacterial co‑infection had a negative 
effect on SIV replication. The real cause of this effect is 
unknown, but the authors hypothesized that the reduc‑
tion in the amount of released virus may be caused by the 
direct binding of virions to bacteria and/or a detrimental 
effect caused by bacteria bound to the surface of infected 
cells [80]. Further studies are needed to elucidate this 
effect.
The presence of differentiated epithelial cells and 
mucus in animal respiratory mucosa creates additional 
complexity that could not be replicated with epithelial 
cell lines. To overcome this limitation, Meng et al., estab‑
lished a porcine precision‑cut lung slice (PCLS) co‑infec‑
tion model [81]. PCLSs use a procedure that preserves 
multicellular tissue consisting of ciliated cells, mucus‑
producing cells and pneumocytes [81]. Hence, the pres‑
ence of differentiated epithelial cells with preserved 
functions in this model made it possible to study S. suis 
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interactions in an environment that more closely resem‑
bles an in  vivo respiratory mucosal surface [81]. PLCSs 
were pre‑infected with SIV subtypes H1N1 or H2N3 and 
subsequently co‑infected with an S. suis serotype 2 strain 
[81]. As shown in previous studies [79, 80], the adhesion 
of S. suis to epithelial cells was significantly increased by 
SIV in a bacterial capsule‑dependant manner, especially 
in the early stage [81]. However, at a later stage of co‑
infection, results were virus strain‑dependent, since only 
SIV H3N2 induced the increased attachment of not only 
the encapsulated S. suis but also of its non‑encapsulated 
mutant [81]. Indeed, confocal microscopy of cryosections 
showed the destruction of ciliated epithelial cells and an 
increased presence of both encapsulated and non‑encap‑
sulated S. suis in the sub‑epithelium of PLCSs [81]. These 
results imply that SIV promotes the bacterial infection 
of respiratory epithelial cells in two phases, depending 
on viral subtype. The first phase is at the beginning of 
the infection, when adherence of bacteria is enhanced by 
viral hemagglutinin (from both virus subtypes) expressed 
on the surface of the epithelial cells that bind S. suis cap‑
sular polysaccharide sialic acid moiety. The second phase 
occurs later when SIV H3N2 damages the epithelial cells 
and opens the path for the bacterial colonization of the 
subepithelial tissue in a capsule (and sialic acid)‑inde‑
pendent manner [81].
To better resemble the luminal respiratory environ‑
ment in airway epithelium, an air–liquid interface (ALI) 
culture system for differentiated porcine airway epithelial 
cells was developed [82]. Primary porcine tracheal and 
bronchial epithelial cells were cultured in a Transwell 
filter system that enables the differentiation of epithelial 
cells under air–liquid interface conditions [82]. Indeed, 
the cell monolayer acquired cilia, pseudostratified epi‑
thelium and tight junctions that resemble the cells of air‑
way epithelium in a live animal [82]. The model was first 
used to evaluate the adhesion and cytotoxic properties 
of S. suis serotype  2, showing that the hemolysin pro‑
duced by S. suis (suilysin) contributes to the loss of cili‑
ated cells and cell apoptosis, as well as bacterial adhesion 
and invasion (76). The same system was further devel‑
oped to examine the interactions of SIV H3N2 and S. suis 
serotype  2 [83]. The previous infection of cells with the 
virus increased S. suis sialic acid‑dependent adherence 
and colonization, once more confirming previous studies 
[79–81]. There was a prominent difference in cytopatho‑
genicity observed during the single infection with the 
bacteria or SIV in this study. S.  suis infection resulted 
in early destruction of the differentiated cells, while 
SIV H3N2 induced apoptosis in the later stage of infec‑
tion. It was suggested that S. suis cytopathogenicity may 
be due to the suilysin, since a mutant defective in the pro‑
duction of the toxin adhered but did not damage the cells 
during the mono‑infection. When SIV H3N2 was present 
in a co‑infection study using both wild‑type and suilysin‑
negative mutant strains, the latter was also able to adhere 
and invade deeper layers of differentiated epithelial cells 
[83]. Indeed, the authors propose that suilysin‑negative 
S. suis strains, which are common in North America [2], 
can become invasive in a co‑infection scenario with influ‑
enza A viruses.
The role of inflammation through an increase of the 
expression of pro‑inflammatory mediators has been 
described for both S. suis and SIV [84]. A preliminary 
study showed that co‑infection significantly increased 
the expression of proinflammatory genes [79]. A more 
detailed study on gene expression in NTPr cells dur‑
ing S. suis and SIV H1N1 co‑infection using a microar‑
ray assay confirmed that the infection of cells with SIV 
H1N1 alone or co‑infection with both pathogens induced 
higher mRNA expression of genes in different biological 
categories than cells infected by S. suis alone, with genes 
involved in immune response and inflammation being 
particularly overexpressed [85]. This synergy may be the 
consequence, at least in part, of an increased bacterial 
adhesion/invasion of epithelial cells previously infected 
by SIV.
4.2.3  In vivo studies on the interaction between S. suis 
and SIV
Because S. suis and SIV co‑infection became of interest 
just recently, there is only one published animal model 
(Table 2). Lin et al. developed an in vivo model in which 
five‑week‑old piglets were intranasally infected with SIV 
H1N1 and then intranasally co‑infected with a (suilysin 
positive) S. suis serotype  2 strain three days later [76]. 
The co‑infected group showed more severe clinical signs 
and viral‑induced pneumonia compared to the virus or S. 
suis single‑infected groups [76]. The results confirmed, 
at least in part, the clinical and epidemiological field 
data from England in which clinical signs seemed to be 
aggravated in co‑infected animals [77]. Interestingly, the 
viral loads in the lungs were significantly higher in the co‑
infected group compared to the control group infected 
with either bacteria or SIV H1N1 alone, thus contradict‑
ing previous in  vitro observations on a possible inhibi‑
tory role of S. suis on virus replication [80]. Moreover, 
the bacterial load was not increased in the co‑infected 
group compared to the S. suis‑infected group [76]. 
Results also showed significant upregulation changes 
in genes involved in pro‑inflammatory (TLR4, MyD88, 
IL‑17D, IL‑6, IL‑8 and CCL2) and apoptosis (CASP2, 
CASP3, BCL2L11, FASLG and TNFRSF8) in the co‑
infected group compared to the control mono‑infected 
groups [76]. These results confirm previous observations 
in  vitro using tracheal epithelial cells [79]. In sum, the 
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study results confirm a synergic clinical and pathological 
effect of SIV H1N1 and S. suis serotype 2 in pigs. How‑
ever, from the mechanistic perspective, this study did not 
characterize the immune cells involved in the generation 
of mucosal and systemic immune responses.
The characterization of molecular and immunological 
aspects of co‑infections in pigs may also contribute to a 
better understanding of disease in human medicine [86]. 
Indeed, as mentioned, human influenza disease is often 
complicated by secondary pneumonia caused by S. pneu-
moniae, which leads to significant morbidity and mor‑
tality around the world [72]. However, the mechanisms 
involved in this co‑infection are also partially known [72].
4.3  S. suis and porcine circovirus 2 mixed and co-infections
Porcine circoviruses (PCVs) single‑stranded DNA viruses 
that belong to the genus Circovirus under the family Cir-
coviridae [87]. Four types of PCVs have been described: 
PCV‑1, PCV‑2, PCV‑3 and PCV‑4 [88]. PCV‑2 is, by far, 
the most important PCV for the swine industry and is 
found to be associated with multiple clinical manifesta‑
tions of the disease in pigs referred to as porcine circovi‑
rus diseases (PCVD) in Europe and as porcine circovirus 
associated disease (PCVAD) in North America [89, 90]. 
The clinical signs of PCVD/PCVAD were first described 
as a postweaning multisystemic wasting syndrome 
(PMWS, currently known as PCV‑2‑systemic disease, 
PCV‑2‑SD) in Canada [91]. PCV‑2 was also associated 
with the porcine dermatitis and nephropathy syndrome 
and with enteritis [92–94]. However, the most prevalent 
form detected in the field is as PCV‑2 subclinical infec‑
tions [95].
4.3.1  PCV‑2‑S. suis mixed infections
An analysis of 484  field cases of PCV‑2‑SD in the USA 
revealed that most cases were in association with other 
pathogens and only 1.9% of investigated cases were 
caused by PCV‑2 alone [96]. PCV‑2 was most often 
detected with PRRSV (51.9%) and M. hyopneumoniae 
(35.5%) [96]. Bacterial septicemia and bacterial pneu‑
monia were detected in 14% and 7.6% of the PCV‑2‑SD 
cases, respectively [96]. The most prevalent bacteria 
detected in bacterial septicemia cases was S. suis. A simi‑
lar 2009 study on PCV‑2 mixed infections from the same 
region yielded similar results, with S. suis found in 
around 35% of PCV‑2‑SD cases with bacterial septice‑
mia [97]. Furthermore, a qPCR assay was applied in a 
retrospective epidemiological survey of 121  PCV‑2‑SD 
cases from Canadian farms to examine the association 
between PCV‑2 and other swine pathogens [98]. The 
study revealed that high PCV‑2 loads increased the odds 
ratio of isolating A. pleuropneumoniae and S. suis  sero‑
types 1/2, 1, 2, 3, 4 and 7 from respiratory samples [98], 
but no clear correlation with disease could be established. 
Another study detected the presence of both pathogens 
by qPCR in oral fluid samples [46] but, similarly, no asso‑
ciation with the disease was observed. However, the per‑
centage of PCV‑2 PCR positive results increased with 
age, whereas positive results for S. suis showed the oppo‑
site, indicating that perhaps both pathogens are not nec‑
essarily prevalent at the same time [46]. Taken together, 
although epidemiological results might suggest a possible 
role of S. suis as a complication of PCV‑2‑associated dis‑
eases, no clear data confirm this hypothesis.
4.3.2  In vitro studies on the interaction between S. suis 
and PCV‑2
Only three in  vitro co‑infection studies have been per‑
formed using different cell types to study S. suis and 
PCV‑2 co‑infection (Table  1) [21, 99, 100]. The results 
of the first study, which used poorly characterized 
immortalized swine tracheal epithelial cells, showed 
that although no increased adhesion or invasion of S. 
suis serotype  2 was observed, the virus pre‑infection 
decreased the expression levels of ZO‑1 and occlu‑
din, increased cell permeability and contributed to the 
translocation of S. suis serotype  2 across the tracheal 
epithelium [99]. Although this in  vitro model suggests 
a possible role of PCV‑2 during the initial steps of co‑
infection by S. suis, the level of replication of PCV‑2 in 
tracheal and other respiratory epithelia in pigs is limited, 
since PCV‑2 infects mainly lymphoblast and monocytes 
(101). Therefore, the impact of the described viral effect 
in this study is somehow controversial.
In a complementary study by the same research group 
and using the same cells (with the same limitations), the 
authors suggested that a previous PCV‑2 cell infection 
would enhance bacterial intracellular survival through 
a decrease in reactive oxygen species. Moreover, the co‑
infection of tracheal cells with PCV‑2 and S. suis would 
be responsible for a downregulation of the expression of 
pro‑inflammatory cytokines, which would weaken the 
host’s defensive response [100]. The results, which have 
yet to be confirmed, must be interpreted carefully since it 
has been largely reported that inflammation plays a major 
role in the pathogenesis of PCV‑2 infections. Again, these 
results should be carefully interpreted.
In the third in vitro study, a co‑infection of the porcine 
monocytic cell line 3D4/21 with PCV‑2 and S. suis sero‑
type  2 induced a significant upregulation of the expres‑
sion of pro‑inflammatory cytokines as well as TLR2, 
compared to single‑infected cells [21]. The upregulation 
of TLR4 was mainly induced by PCV‑2, whereas the 
downregulation of MHC‑II was observed mostly with S. 
suis [21]. Results may indicate a possible role of the co‑
infection on increased inflammation and the modulation 
Page 13 of 22Obradovic et al. Vet Res           (2021) 52:49  
of antigen presentation, although more studies are 
required to confirm the hypothesis.
4.3.3  In vivo studies on the interaction between S. suis 
and PCV‑2
There is only one in  vivo study using both pathogens 
(Table 2) [21]. In this model, four‑week‑old piglets were 
infected with a PCV‑2 strain through intranasal and 
intramuscular inoculation. Five days later, the animals 
were intranasally and intramuscularly challenged with 
a S. suis serotype  2  strain. Compared to single‑infected 
pigs, the co‑infected group showed higher temperatures 
and lower weight gains. The amounts of S. suis in the 
internal organs of co‑infected animals were inconsist‑
ently and slightly higher than those in the S. suis‑infected 
group, although the biological significance of the results 
has yet to be confirmed. Co‑infected animals had higher 
scores of clinical signs and lesions of pneumonia, myo‑
carditis and arthritis compared to single‑infected animals 
[21]. Peripheral blood mononuclear cells collected from 
co‑infected piglets showed higher expression levels of 
inflammatory cytokines, TLR2 and TLR4 and reduced 
levels of CD4, CD8 and MHC‑II. It was also shown that 
PCV‑2 disrupted the integrity and decreased mRNA and 
protein levels of tight junctions in the lungs of co‑infected 
animals [99]. Although the authors showed a reduced 
antibody response against S. suis in virus‑infected ani‑
mals, a poorly characterized commercial kit available in 
China only was used [21]. Currently, there is no widely 
scientifically accepted test to measure antibodies against 
S. suis [2]. More studies using other strains and different 
animal models must be conducted to confirm the results.
4.4  S. suis and other virus co-infections
The worldwide distribution and high prevalence of S. suis 
in pig herds increase the possible interactions with mul‑
tiple viruses. Co‑infections of S. suis with pseudorabies 
virus (PRV) and Nipah virus have been recorded in the 
field and experimentally studied in pigs. The common 
characteristics of S. suis, PRV and Nipah virus are that 
they invade through the respiratory epithelium, have tro‑
pism for neurological tissue and are zoonotic pathogens.
PRV, also known as Aujeszky’s disease virus, has a sig‑
nificant economic importance for the pig industry [102]. 
Infected pigs have respiratory or neurological clini‑
cal signs with subsequent high mortality [103]. Pigs are 
natural hosts, although other domestic and wild animals 
may also be infected [104], and the disease has zoonotic 
potential [105]. PRV may be associated with other viral 
pathogens, such as PCV‑2, and may be detected together 
using PCR in clinically ill pigs and aborted fetuses [106]. 
It was speculated that due to the prevalence of S. suis in 
pig herds, PRV co‑infection can aggravate respiratory 
and neurological outcomes. In an experimental study, 
nine‑week‑old piglets were intranasally inoculated with 
S. suis and a high or low virulent PRV strain (Table  2). 
Interestingly, both PRV strains induced more severe S. 
suis clinical signs in co‑infected piglets [107]. The biolog‑
ical relevance of this type of co‑infection is still not clear 
since there are no recent experimental or epidemiologi‑
cal data evaluating S. suis and PRV associations. PRV has 
been eradicated from many countries and, when present, 
vaccination has been used to successfully prevent Aujesz‑
ky’s disease in pigs. This may partly explain the reason 
why research into its association with other pathogens is 
scarce [101].
Nipah virus is a single‑stranded non‑segmented RNA 
virus belonging to the family of Paramyxoviridae [108, 
109]. It causes disease in multiple animal species with 
fruit bats and flying foxes being the main reservoirs 
[108, 110, 111]. Pigs could be naturally infected, but the 
infection is often asymptomatic with the virus present 
in nasal cavities [112]. In experimental studies, young 
piglets displayed pronounced respiratory clinical signs, 
while older pigs had predominantly neurological clinical 
signs [113, 114]. Nipah virus has significant public health 
impact, since it causes disease in humans, especially in 
East and Southeast Asia [115], where human infection 
caused by S. suis is also predominant [49]. In the case of 
experimental oronasal infection in six‑week‑old piglets 
with Nipah virus, it was observed that the piglets with 
aggravated respiratory clinical signs had S. suis isolated 
from the respiratory tissue [116]. This finding should be 
carefully considered, since bacteria were already present 
in infected pigs (healthy carriers) and the isolation of S. 
suis was merely accidental [116]. As discussed above, the 
presence of S. suis in the respiratory tissue does not prove 
the involvement of the bacteria in respiratory disease. 
Although further studies are required to elucidate the rel‑
evance of S. suis and Nipah virus co‑infection, there are 
technical and economic obstacles to develop pig experi‑
mental co‑infection models. The Nipah virus is a biose‑
curity level 4 pathogen that requires strict measures and 
special research facilities that are not widely available.
5  S. suis mixed and/or co‑infections with other 
bacterial pathogens
Described mixed swine bacterial infections concern 
mainly respiratory pathogens involved in the PRDC, 
such as M. hyopneumoniae, Mycoplasma hyorhinis, A. 
pleuropneumoniae, Actinobacillus suis, Glaesserella par-
asuis, Bordatella bronchiseptica, Pasteurella multocida 
and S. suis [42]. As discussed previously, some are pri‑
mary pathogens (mainly A. pleuropneumoniae and M. 
hyopneumoniae), while others are considered secondary 
pathogens (S. suis and G. parasuis) [17, 42]. There are 
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very few real co‑infection studies of S. suis with other 
bacteria, and most reports address mixed infections.
5.1  S. suis mixed infections with other bacterial pathogens
One of the main problems of most studies is that mixed 
infections are described at the abattoir [32, 117]. For 
primary respiratory pathogens that induce fairly typi‑
cal lesions and affect grower‑finisher animals (such as 
A. pleuropneumoniae), the studies are appropriate [118]. 
When available, the combination of serological surveys 
based on validated antibody detection techniques (for 
example against A. pleuropneumoniae and M. hyopneu-
moniae) at the herd level along with the presence of 
lesions at slaughter may indicate the pathogens’ involve‑
ment in the pulmonary pathology of pigs [119]. However, 
for a secondary respiratory pathogen such as S. suis that 
mainly affect nursery piglets and for which validated 
serological tests are not available, the studies are far less 
relevant. As mentioned above, S. suis sometimes colo‑
nizes the lungs pre‑ or ante‑mortem without playing any 
major pathological role in pneumonia [2, 119].
Early studies with organs recovered from diseased 
pigs showed that S. suis was frequently isolated in con‑
junction with A. pleuropneumoniae, P. multocida, E. coli 
and many other microorganisms, although it is not indi‑
cated exactly how many of these cases were from lungs 
versus other internal organs/tissues [120, 121]. It has 
been reported that S. suis was isolated with many other 
bacterial pathogens in more than 75% of lungs display‑
ing fibrino‑hemorrhagic pneumonia [122]. S. suis and P. 
multocida were isolated together in almost 50% of lungs 
from animals suffering from respiratory clinical signs in 
China [123]. In addition, there was a reported case of 
concurrent lung infection of S. suis and P. multocida in 
conjunction with Pneumocystis carinii [124]. Using more 
sensitive PCR techniques, statistical associations were 
found in samples from lung tissues between PCR‑positive 
results for P. multocida or A. pleuropneumoniae and S. 
suis [32]. Interestingly, a case of pneumonia in a sow with 
mixed infections of S. suis and B. bronchiseptica was also 
described, although S. suis causing disease in adult ani‑
mals is extremely rare [125]. Another study indicated that 
almost 30% of affected lungs yielded common isolation of 
these two pathogens [126]. The association of both S. suis 
and B. bronchiseptica was further studied in in vitro and 
in vivo models (see below). Interesting, there is only one 
report indicating a possible correlation between S. suis 
and M. hyopneumoniae in the lungs [127].
The indication of the involvement of S. suis in mixed 
infections as a cause of pulmonary disease may also be 
found in other animal species. There was a reported 
case of acute death of a racehorse with clinical signs of 
pneumonia during transport in Japan [128]. Pasteurella 
caballi, S. suis and Streptococcus zooepidemicus were iso‑
lated from the lungs, indicating that the cause of pneu‑
monia and subsequent death was due to the bacterial 
mixed infection of the lungs [128]. However, although 
these bacteria were isolated in high loads from lung and 
tracheo‑bronchial lymph nodes, it was not possible to 
determine if they were the primary cause or secondary 
invaders [128]. Furthermore, the transport of the horses 
was lengthy and during winter months—two factors 
that may have created major environmental stress that 
enhanced bacterial growth and susceptibility to infection 
[128].
The isolation of S. suis with other bacterial pathogens 
in tissues other than lungs has also been reported. S. 
suis was isolated with M. hyorhinis or M. hyopneumo-
niae from the pericardium [129]. Another study reported 
mixed infections of G. parasuis and S. suis in cases of 
polyserositis [130]. Both pathogens were also detected 
together in more than 30% of samples, although the tis‑
sue/organ of origin (lungs versus internal organs) was not 
reported [131]. Finally, a case of abortion with dual iso‑
lation of S. suis and Arcobacter spp was described [132]. 
Mixed infections caused by different serotypes of S. suis 
should also be considered, as there have been recorded 
cases of meningitis and septicemia in a seven‑week‑old 
piglet caused by S. suis serotype  3  cultured from the 
spleen and bursa and a S. suis serotype 7 recovered from 
the cerebrospinal fluid [133]. It should be noted that all 
cases discussed in this section represent sporadic mixed 
bacterial infections without any clear indication of the 
specific role of co‑infections in the development of 
disease.
5.2  In vitro and in vivo studies on the interaction 
between S. suis and other bacterial pathogens
One in  vitro study addressed a co‑infection between S. 
suis and G. parasuis using NTPr cells and PAMs (Table 3) 
[54]. G. parasuis is a causative agent of Glässer’s disease 
in pigs. Similar to S. suis, low virulent strains colonize 
the upper respiratory epithelial surface of healthy ani‑
mals, while high virulent strains can cross the epithelial 
barrier and cause mainly systemic disease and (probably) 
pneumonia (as a secondary invader) [134]. The disease is 
characterized by polyserositis and polyarthritis [134]. G. 
parasuis and S. suis infections also share similar clinical 
signs that frequently represent a challenge in the clini‑
cal differential diagnosis. The in vitro model using NTPr 
cells showed that low and high virulent strains of S. suis 
and G. parasuis have a different pattern of adhesion to 
and invasion of epithelial cells as single infections [54]. 
However, co‑infection studies show limited in vitro inter‑
action between the two bacterial species, which likely use 
different host receptors. Although it has been found that 
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the capsular polysaccharide of S. suis serotype 2 has anti‑
phagocytic properties against a heterologous bacterial 
species, pre‑treatment of PAMs with S. suis did not have 
a clear effect on the phagocytosis of G. parasuis. When 
inflammatory mediators produced by both epithelial and 
PAM co‑infected cells were studied, an additive (but not 
synergistic) effect was observed. Virulence factors of G. 
parasuis and S. suis are not fully known and other condi‑
tions in respiratory mucosa may play an important role in 
G. parasuis and S. suis co‑infections [7, 135].
A recent report suggested that co‑infections between 
A. pleuropneumoniae and S. suis are frequently found in 
China, although no data were presented [136]. However, 
the authors hypothesized that there are synergistic inter‑
actions between both pathogens. They reported that, 
when A. pleuropneumoniae was cultured with S. suis in 
culture media, biofilm formation by A. pleuropneumo-
niae was significantly increased. Moreover, compared to 
cultures with a single bacterium species, the antibiotic 
resistance, as well as the expression of genes coding for 
different (putative) virulence factors of both pathogens, 
were enhanced in the co‑culture model. The authors sug‑
gest that the interspecies interactions between S. suis and 
A. pleuropneumoniae may be cooperative under specific 
conditions and may play an important role in disease 
progression and persistent infection [136]. It should be 
noted, however, that both pathogens affect piglets of dif‑
ferent ages, with A. pleuropneumoniae mainly causing 
disease in grower‑finisher animals and S. suis affecting 
mostly nursery piglets [36]. Indeed, the implications of 
the results obtained in the S. suis‑A. pleuropneumoniae 
co‑infection study should be carefully interpreted, as they 
probably do not reflect the situation in the field.
A last in  vitro study became available very recently 
[137], where the interaction of B. bronchiseptica and 
S. suis was analyzed using the PCLS system previously 
reported (81). Interestingly, the authors established 
conditions where the pre‑infection of B. bronchiseptica 
induced reduction of ciliary activity in the absence of sig‑
nificant toxicity. Under these conditions, it was shown 
that S. suis significantly increase adhesion and coloniza‑
tion, although both pathogens seem to adhere and colo‑
nize different areas of tissue. In addition, the increased 
adhesion of S. suis resulted in higher cytotoxicity due to 
the presence of suilysin [137]. Although not confirmed, 
in vivo experiments suggest that a pre‑infection with B. 
bronchiseptica may promote not only adhesion but also 
invasion into deeper tissues (see below).
In vivo studies are also very limited (Table 4). There is 
one report in which S. suis and Aerococcus viridans were 
isolated together from a pig with meningitis in China 
[138]. A. viridans has been isolated mostly from swine 
and humans [139, 140]. However, because A. viridans is 
a bacterium that is present in the environment, it may 
simply be a contaminant in a sample. To examine the 
potential of S. suis and A. viridans interaction, Pan et al. 
used an intraperitoneal mouse model of co‑infection 
using both bacterial strains recovered from the above‑
mentioned case of meningitis [138]. Results showed that 
the co‑infection significantly increased systemic infec‑
tion and acute meningitis [138]. Titers of S. suis were 
significantly increased in the lungs of co‑infected mice, 
while titers of A. viridans in lungs remained at a low level 
[138]. It should be noticed that colonization of the lungs 
was probably the result of septicemia (due to the injec‑
tion route) and does not indicate a respiratory infection. 
Further research is required to see if these results could 
be reproduced in the swine model and examine the cel‑
lular and molecular mechanisms involved in this type of 
co‑infection. However, it is important to keep in mind 
that his type of co‑infection is almost never observed 
in the field and that the presence of A. viridans in the 
original clinical sample could have simply represented a 
contamination.
Table 4 Summary of the experimental conditions of S. suis co-infection with bacterial pathogens using in vivo models 
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The most important in vivo study has been carried out 
with S. suis and B. bronchiseptica [141]. Interestingly, the 
original goal of the use of B. bronchiseptica in this study 
was simply to predispose pigs to the intranasal infection 
with S. suis. Indeed, as mentioned above, it is difficult to 
reproduce S. suis disease with conventional pigs using 
this route of infection. In this study, a B. bronchiseptica 
strain isolated from the nose of a pig with regressive 
atrophic rhinitis was used. In other words, the study was 
oriented to a local infection (nose) affecting the mucosa 
rather than a lower respiratory infection (lungs). Indeed, 
in further studies, acetic acid was used to replace B. bron-
chiseptica infection [33]. In the co‑infection study, S. suis 
strains that were phenotypically different with regard to 
virulence markers were used. Only S. suis strains that 
harbored the proposed virulence markers were able to 
induce disease. Interestingly, S. suis was detected in the 
lungs with bronchopneumonia only when B. bronchisep-
tica (at higher concentrations) was also present. Indeed, 
B. bronchiseptica was recovered from the lungs of 19 ani‑
mals, whereas S. suis was present in 8  samples. None 
of the samples contained S. suis only. The authors con‑
cluded that S. suis may be considered a secondary agent 
of pneumonia [142]. In  vitro results recently obtained 
and discussed above may explain mechanisms involved 
in the interaction of both bacterial species [137].
The abundance of bacterial pathogens found in epide‑
miological association with S. suis, especially in pneumo‑
nia cases, is not followed by the appropriate number of 
co‑infection studies to understand the role and mecha‑
nisms involved in such interactions. In  vivo studies of 
co‑infection of S. suis with other important bacterial 
pathogens are not available, and it is therefore difficult 
to speculate on the significance of each pathogen in the 
inception of disease.
6  Limitations of S. suis co‑infection studies
Generally speaking, the limitations of co‑infection stud‑
ies are well addressed by Saade et al. [17]. More specifi‑
cally with regard to S. suis, although mixed infections 
studies may be taken into consideration, it is important 
to interpret the data on a real synergic effect in the field 
carefully, and reports from lungs recovered at the abat‑
toir should be avoided. Indeed, the fact that S. suis is a 
normal inhabitant of the upper respiratory tract should 
not be neglected. Regarding in vitro models of co‑infec‑
tion, several have limitations and room for improvement. 
S. suis infection models using different immortalized or 
primary cells are still useful to study the mechanisms of 
gene expression and cellular pathways induced by viruses 
and bacteria and may shed light on the molecular interac‑
tions that occur during co‑infections. It should be noted 
that the choice of cell type and nutritional components of 
the media may have a major impact on pathogen interac‑
tions, growth and survival. For example, the expression of 
certain metabolic and virulent bacterial genes by S. suis 
may be different or reduced in nutritionally rich media 
compared to in  vivo‑like environments [143]. To repro‑
duce cell interactions in a more complex environment, 
the development of ALI and PCLS systems constitutes 
a major improvement to study S. suis co‑infections [81, 
82]. Enhanced in vitro systems such as three‑dimensional 
organotypic tissue models that more closely resemble 
the 3D architecture, cellular composition and matrix 
complexity of the organ may be further developed. The 
adaptability of these tissue‑engineered models to multi‑
ple pathogens suggests significant potential for infectious 
disease studies [86].
In many cases, the innate immune system plays an 
important role in the outcome of the co‑infection and, 
as such, many studies focus on the interaction with the 
immune cells. In comparison with mouse or human 
immunology, there is still a lower number of immunolog‑
ical tools designed to detect and analyze swine immune 
cells [144]. However, since the field of swine immunology 
is evolving rapidly, we can expect that more sophisticated 
immunological tools will be developed in the near future 
and significantly expand our knowledge of the immune 
response induced during these co‑infections.
In general, for many infectious agents, in  vivo mod‑
els of co‑infections are sometimes difficult to reproduce 
[17]. This is even truer when referring to S. suis: 
a. Firstly, S. suis is a normal inhabitant and almost all 
conventional animals used in experimental infections 
are already colonized. Since there are no sensitive 
and specific validated tests (neither PCR nor sero-
logical tests) to evaluate whether animals are carri-
ers of virulent strains, it is difficult to predict how the 
animals will behave after experimental infection. We 
have already recovered S. suis serotypes 1 and 14 iso-
lates from the internal organs (one case for each 
serotype) of animals experimentally infected with 
a virulent serotype 2 strain, possibly due to a previ-
ous infection present in the animals’ herds of origin 
(unpublished observations). On the other hand, the 
use of caesarian-derived, colostrum-deprived piglets 
(highly susceptible to S. suis) constitutes a very use-
ful tool to generate knowledge but somehow remains 
relatively far from the reality of the field.
b. Another issue is that the routes of S. suis inocula-
tion (even with virulent serotype 2 strains) are rather 
artificial (intravenous, intraperitoneal, intramuscu-
lar) due to the difficulties to reproduce the disease in 
conventional animals [16]. A seeder-to-naïve model, 
as developed for other infections such as A. pleuro-
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pneumoniae [145], has yet to be established. In co-
infection studies, these procedures complicate the 
interpretation of the results, since the first pathogen 
frequently infects animals through the respiratory 
tract, and both pathogens should be evaluated under 
similar conditions.
c. As mentioned, the virulence of serotype  2  strains 
from different geographical origins may be different 
[2], and almost no co-infection studies were con-
ducted with well-characterized North American 
serotype 2 strains with lower virulence capacity when 
compared to their Eurasian counterparts.
d. There are almost no studies with serotypes other 
than serotype 2, such as serotype 1/2 which is highly 
prevalent in North America. This is mainly due to the 
fact that experimental infection models with non-
serotype 2 strains are rarely developed.
e. Environmental and management factors may highly 
influence the development of the disease by S. suis. 
These factors are usually not present under experi-
mental conditions in well-controlled research envi-
ronments. In this regard, recent experiments on S. 
suis mucosal infection models tried to mimic, at least 
in part, the weaning stress that piglets experience 
under field conditions by applying several stressors, 
like transport and social stresses [4].
7  Conclusion and future perspectives
Co‑infections of S. suis with important swine patho‑
gens have been addressed in recent studies, and new 
mechanisms of pathogen interactions of viral and bacte‑
rial pathogens have been proposed. However, owing to 
the importance given to co‑infections in S. suis‑associ‑
ated diseases, the number of studies (mostly addressing 
mechanisms) is considerably low. In general, viral patho‑
gens such as SIV may destroy the epithelial barrier and 
increase the permeability of the mucosal surface, while 
PRSSV may have a negative impact on the functions of 
pulmonary alveolar and intravascular macrophages and 
PCV‑2 has a strong tropism for lymphoblasts. However, 
how these mechanisms actually affect S. suis pathogenic‑
ity is still debatable. Similarly, an increased inflammation 
(a hallmark of S. suis infections) caused by co‑infection 
with other pathogens may also play an important role. 
However, most co‑infection studies showing upregula‑
tions of inflammatory mediators were conducted in vitro 
and the data must still be validated in  vivo within the 
natural host. Finally, data on co‑infections (and mecha‑
nisms involved) of S. suis with other bacterial pathogens 
are mostly unavailable.
Saade et al. made general recommendations for future 
co‑infection studies [17]. These recommendations may 
be adapted to S. suis co‑infection studies: (i) authors 
should clearly indicate and characterize the S. suis 
strains used (e.g., serotype, sequence type, presence 
of virulence markers and other phenotypic character‑
istics); (ii) well‑characterized S. suis strains of sero‑
types other than type 2 should also be used, especially 
in North American studies in which other serotypes 
(e.g., serotype  1/2) may be more prevalent than sero‑
type  2; (iii) in in  vivo studies, the route of infection 
should follow the natural infection of both pathogens, 
which should be able to interact in the same environ‑
ment; (iv) since S. suis mainly causes disease in nurs‑
ery piglets, co‑infection studies should mostly address 
pathogens affecting animals at a similar age; (v) no test 
is specific or sensitive enough to monitor the status of 
S. suis infection in a herd. Authors should avoid refer‑
ring to the use of S. suis serotype 2-free animals based 
on serological (no scientific test available) and/or ton‑
sillar PCR evaluations, being the latter low sensitive. 
Although some genes involved in the susceptibility 
or resistance to S. suis disease have been suggested in 
mice [143], no study has addressed the issue in pigs, 
and it is therefore not possible to identify animals sus‑
ceptible to the infection yet; (vi) authors should try to 
use animals from farms with no or limited clinical cases 
(and serotype different from the one to be evaluated) of 
S. suis where no prophylactic/metaphylactic procedures 
are in place at the nursery; (vii) re‑isolation of S. suis, 
serotyping and, if possible, pathotyping are mandatory 
in experimental co‑infection studies using conventional 
animals, since S. suis other than the strain used during 
the co‑infection may be isolated from diseased animals, 
especially the lungs. Improved and more standardized 
models will generate new data on the intricate process 
of S. suis interactions with major swine pathogens.
Finally, there may be additional effects of a previous 
infection with a pathogen on a secondary S. suis infec‑
tion. For example, it has been reported that a previous 
infection with PRRSV may alter the efficacy of cefti‑
ofur treatment of S. suis co‑infection [146]. Whether a 
previous virus infection affects the antibody and pro‑
tective response of S. suis autogenous vaccines is also 
unknown [26].
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